NCT07104201View on ClinicalTrials.gov

Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

March 13, 2025

Primary Completion Date

March 31, 2035

Study Completion Date

March 31, 2035

Conditions

Primary Biliary Cholangitis (PBC)

Interventions

DRUG

Fenofibrate

Fenofibrate 200mg

Trial Locations (1)

710032

RECRUITING

Xijing Hospital, Xi'an

All Listed Sponsors

lead

Xijing Hospital of Digestive Diseases

OTHER